Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
SBI Mutual Fund · Managed by Tanmaya Desai
100strong
Latest NAV
₹603.3454
as of 18 Aug 2026
AUM
—
Expense ratio
1.03%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
100/100strong
Rank #9 of 1015 · top 1%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
3.90%
3M
11.93%
6M
24.05%
1Y
21.36%
3Y CAGR
24.81%
5Y CAGR
18.95%
Since incep.
18.42%
Fund details
- Fund manager
- Tanmaya Desai
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 33%
- Volatility (3Y)
- 16.2%
- Rating (external)
- —
Investment objective
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap40.2%
Mid cap25.0%
Small cap34.8%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 31 Jul 2026.
Sun Pharmaceutical Industries Ltd.
equity
12.72%
Divi's Laboratories Ltd.
equity
7.46%
Acutaas Chemicals Ltd.
equity
5.17%
Cipla Ltd.
equity
5.07%
Apollo Hospitals Enterprise Ltd.
equity
4.98%
Torrent Pharmaceuticals Ltd.
equity
4.74%
Max Healthcare Institute Ltd.
equity
4.58%
Laurus Labs Ltd.
equity
4.04%
Aurobindo Pharma Ltd.
equity
3.86%
Aster DM Quality Care Ltd.
equity
3.65%
Biocon Ltd.
equity
2.96%
Jupiter Life Line Hospitals Ltd.
equity
2.88%
Anthem Biosciences Ltd.
equity
2.82%
Gland Pharma Ltd.
equity
2.78%
Fortis Healthcare Ltd.
equity
2.63%
Sai Life Sciences Ltd.
equity
2.44%
Aether Industries Ltd.
equity
2.28%
Sudeep Pharma Ltd.
equity
2.22%
Polymedicure Ltd.
equity
2.02%
Krishna Institute of Medical Sciences Ltd.
equity
1.98%
Ajanta Pharma Ltd.
equity
1.93%
Concord Biotech Ltd.
equity
1.89%
Mankind Pharma Ltd.
equity
1.83%
Lupin Ltd.
equity
1.79%
Cohance Lifesciences Ltd.
equity
1.73%
Global Health Ltd.
equity
1.67%
Nephrocare Health Service Pvt. Ltd.
equity
1.20%
Dr. Lal Path labs Ltd.
equity
1.06%
Abbott India Ltd.
equity
1.03%
Syngene International Ltd.
equity
0.96%